| Mechanism | Key molecular players | Evidence type | Key findings/statistics | Suggested GO biological process terms | Suggested cell type (CL) and anatomical (UBERON) terms | Key citation IDs |
|---|---|---|---|---|---|---|
| RNA toxicity | **FMR1** premutation RNA (55–200 CGG repeats), RNA-binding proteins, reduced **FMRP** | Human clinical/review; human postmortem transcriptomics | FXTAS is driven in part by elevated **FMR1** mRNA with toxic gain-of-function; early foundational review states the mechanism is related to “overexpression and toxicity of the FMR1 mRNA per se.” In human brain snRNA-seq, **FMR1** upregulation was modest in some glial populations (~**1.3-fold** rather than 4–8-fold reported in blood), supporting tissue- and cell-type-specific RNA toxicity; study analyzed **7 premutation carriers vs 6 controls** and **>120,000 nuclei** from frontal cortex and cerebellum (pqac-00000001, pqac-00000010, pqac-00000016) | GO:0006396 RNA processing; GO:0009451 RNA modification; GO:0034645 cellular macromolecule biosynthetic process; GO:0010467 gene expression | CL:0000125 glial cell; CL:0000630 neuron; UBERON:0001870 frontal lobe; UBERON:0002037 cerebellum | (pqac-00000001, pqac-00000010, pqac-00000016) |
| RAN translation / FMRpolyG toxicity | Expanded CGG repeat, **FMRpolyG**, translational machinery, sequestered proteins | Review/human disease synthesis | Recent multidisciplinary review lists production of toxic **FMRpolyG** among major pathogenic mechanisms, alongside RNA toxicity, reduced FMRP, oxidative stress, and calcium dysregulation. Evidence in the retrieved context is primarily review-level rather than quantitative primary clinical statistics (pqac-00000016) | GO:0006412 translation; GO:0031126 cytoplasmic translational initiation; GO:0031047 gene silencing by RNA; GO:0061684 chaperone-mediated autophagy | CL:0000630 neuron; CL:0000127 astrocyte; UBERON:0000955 brain; UBERON:0002037 cerebellum | (pqac-00000016) |
| Inclusion formation / SUMOylation–autophagy dysfunction | **SUMO2/3**, ubiquitin, **p62/SQSTM1**, autophagosomes, proteostasis machinery | Human postmortem brain; patient-derived skin fibroblasts; RNA-seq/gene-set analysis | Neuropathologic hallmark is intranuclear inclusions in neurons and astrocytes. Nearly **200 proteins** have been identified in FXTAS inclusions, with **SUMO2**, ubiquitin, and **p62** among the most abundant. 2023 study found FXTAS postmortem brains positive for **SUMO2/3** conjugates; RNA-seq indicated **SUMOylation upregulated**; fibroblasts showed **p62 accumulation** and autophagosome accumulation; gene-set analysis showed **downregulation of autophagy-related GO terms** (pqac-00000009, pqac-00000003) | GO:0016567 protein ubiquitination; GO:0016925 protein sumoylation; GO:0006914 autophagy; GO:0006511 ubiquitin-dependent protein catabolic process | CL:0000630 neuron; CL:0000127 astrocyte; UBERON:0000955 brain; UBERON:0002037 cerebellum | (pqac-00000009, pqac-00000003) |
| Mitochondrial dysfunction / oxidative stress | Mitochondria, **VDAC**, ER-mitochondria contact sites, ROS, respiratory-chain complexes, calcium homeostasis | Review of human/model/cell evidence; small open-label therapeutic signal | 2024 review links FXTAS to impaired mitochondrial protein import/transport, altered mitochondrial morphology, disrupted calcium handling, reduced respiratory-chain activity, elevated ROS/lipid peroxidation/protein carbonylation, and impaired antioxidant defenses. A small **12-week** open-label allopregnanolone study in **6 males** reportedly reduced oxidative stress and improved mitochondrial function (pqac-00000014, pqac-00000026) | GO:0005739 mitochondrion; GO:0006979 response to oxidative stress; GO:0007005 mitochondrion organization; GO:0006874 cellular calcium ion homeostasis; GO:0006119 oxidative phosphorylation | CL:0000127 astrocyte; CL:0000630 neuron; UBERON:0000955 brain; UBERON:0002037 cerebellum | (pqac-00000014, pqac-00000026) |
| Glial / oligodendrocyte dysregulation | **FMR1/FMRP** networks, oligodendrocyte-lineage genes, glial transcriptional programs | Human postmortem single-nucleus RNA-seq | PNAS 2023 identified cell type–, disease type–, and region-specific transcriptional perturbations, with notable network dysregulation in the **cortical oligodendrocyte lineage**. Pseudotime analyses suggested altered **early oligodendrocyte** gene expression, implicating glial dysfunction as an upstream contributor to white-matter pathology. Dataset: **7 premutation carriers**, **6 controls**, **>120,000 nuclei** from frontal cortex and cerebellum (pqac-00000010) | GO:0042552 myelination; GO:0048709 oligodendrocyte differentiation; GO:0007268 synaptic transmission; GO:0014003 oligodendrocyte development | CL:0000128 oligodendrocyte; CL:0000127 astrocyte; UBERON:0001870 frontal lobe; UBERON:0002037 cerebellum | (pqac-00000010) |
| White matter disease / cerebellar peduncle pathology | Middle cerebellar peduncles (MCP), corpus callosum splenium, dentate nucleus, iron dysregulation, CGG repeat size | MRI biomarker studies; clinical-radiologic correlation; review | MRI hallmark is the **MCP sign** (T2 hyperintensity in middle cerebellar peduncles). Among premutation carriers aged ≥45 years, MCP sign was seen in **52%** of carriers and **0%** of controls; it associated with impaired motor and executive function. Review evidence notes MCP hyperintensities in about **60% of male FXTAS** cases and progressive white-matter lesion burden/atrophy correlating with stage and cognition. MCP width may be an early biomarker and was reduced in premutation carriers who later converted to FXTAS (pqac-00000013, pqac-00000006, pqac-00000001) | GO:0042552 myelination; GO:0007417 central nervous system development; GO:0007601 visual perception; GO:0051962 positive regulation of nervous system development | CL:0000128 oligodendrocyte; CL:0000540 neuron of cerebellum; UBERON:0001950 middle cerebellar peduncle; UBERON:0002037 cerebellum; UBERON:0001885 corpus callosum | (pqac-00000013, pqac-00000006, pqac-00000001) |


*Table: This table summarizes the main proposed pathophysiologic mechanisms in fragile X-associated tremor/ataxia syndrome, linking molecular players to evidence type, quantitative findings, and suggested ontology terms. It is useful for building structured disease knowledge-base entries across mechanism, cell type, and anatomy fields.*